Antioxidative potential of antidiabetic agents: A possible protective mechanism against vascular complications in diabetic patients
dc.creator | Yaribeygi H. | |
dc.creator | Butler A.E. | |
dc.creator | Barreto G.E. | |
dc.creator | Sahebkar A. | |
dc.date.accessioned | 2020-09-02T22:30:36Z | |
dc.date.accessioned | 2022-11-08T20:17:50Z | |
dc.date.available | 2020-09-02T22:30:36Z | |
dc.date.available | 2022-11-08T20:17:50Z | |
dc.date.created | 2020-09-02T22:30:36Z | |
dc.date.issued | 2019 | |
dc.identifier | 234, 3, 2436-2446 | |
dc.identifier | 00219541 | |
dc.identifier | https://hdl.handle.net/20.500.12728/6643 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/5142466 | |
dc.language | en | |
dc.publisher | Wiley-Liss Inc. | |
dc.subject | antidiabetic medications | |
dc.subject | diabetes | |
dc.subject | diabetic nephropathy (DN) | |
dc.subject | oxidative stress | |
dc.subject | vascular dysfunction | |
dc.subject | 2,4 thiazolidinedione derivative | |
dc.subject | antidiabetic agent | |
dc.subject | biguanide derivative | |
dc.subject | dipeptidyl peptidase IV inhibitor | |
dc.subject | glucagon like peptide 1 receptor agonist | |
dc.subject | insulin | |
dc.subject | sodium glucose cotransporter 2 inhibitor | |
dc.subject | sulfonylurea derivative | |
dc.subject | antidiabetic agent | |
dc.subject | antioxidant | |
dc.subject | antioxidant activity | |
dc.subject | diabetic complication | |
dc.subject | diabetic patient | |
dc.subject | drug mechanism | |
dc.subject | human | |
dc.subject | nonhuman | |
dc.subject | oxidative stress | |
dc.subject | priority journal | |
dc.subject | Review | |
dc.subject | vascular disease | |
dc.subject | cardiovascular disease | |
dc.subject | diabetes mellitus | |
dc.subject | diabetic angiopathy | |
dc.subject | drug effect | |
dc.subject | glucose blood level | |
dc.subject | metabolism | |
dc.subject | pathology | |
dc.subject | quality of life | |
dc.subject | Antioxidants | |
dc.subject | Blood Glucose | |
dc.subject | Cardiovascular Diseases | |
dc.subject | Diabetes Mellitus | |
dc.subject | Diabetic Angiopathies | |
dc.subject | Humans | |
dc.subject | Hypoglycemic Agents | |
dc.subject | Oxidative Stress | |
dc.subject | Quality of Life | |
dc.title | Antioxidative potential of antidiabetic agents: A possible protective mechanism against vascular complications in diabetic patients | |
dc.type | Review |